Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 14, 2024 (filed on Apr 15, 2024)Insider Name:Muzzey DaleOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-940Price:$19.55
-
Apr 14, 2024 (filed on Apr 15, 2024)Insider Name:Verratti MarkOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,076Price:$19.55
-
Apr 06, 2024 (filed on Apr 08, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-581Price:$20.26
-
Mar 25, 2024 (filed on Mar 27, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-363Price:$21.98
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-580Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-401Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Haas Kevin RichardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,718Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Haas Kevin RichardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,172Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Muzzey DaleOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-561Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Muzzey DaleOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-382Price:$22.24
Filings by filing date
-
Apr 14, 2024 (filed on Apr 15, 2024)Insider Name:Muzzey DaleOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-940Price:$19.55
-
Apr 14, 2024 (filed on Apr 15, 2024)Insider Name:Verratti MarkOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,076Price:$19.55
-
Apr 06, 2024 (filed on Apr 08, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-581Price:$20.26
-
Mar 14, 2024 (filed on Mar 28, 2024)Insider Name:Leffler Scott J.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:46,905Price:--
-
Mar 25, 2024 (filed on Mar 27, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-363Price:$21.98
-
Mar 22, 2024 (filed on Mar 25, 2024)Insider Name:Wong PamelaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-1,441Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-580Price:$22.24
-
Mar 24, 2024 (filed on Mar 25, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-401Price:$22.24
-
Mar 22, 2024 (filed on Mar 25, 2024)Insider Name:Munk NatalieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-363Price:$22.24
-
Mar 22, 2024 (filed on Mar 25, 2024)Insider Name:Ancona MargaretOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-730Price:$22.24
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 322 North 2200 West SALT LAKE CITY UT 84116 |
Tel: | 1-801-5843532 |
Website: | https://myriad.com |
IR: | See website |
Key People | ||
Paul J. Diaz President, Chief Executive Officer, Director | Pamela Wong Chief Legal Officer | Scott J. Leffler Chief Financial Officer, Principal Financial Officer |
George Daneker President, Chief Clinical Officer - Oncology | Sam Raha Chief Operating Officer | Shereen Solaiman Chief People Officer |
Margaret Ancona Senior Vice President, Chief of Staff | Kevin R. Haas Chief Technology Officer | Dale Muzzey Chief Scientific Officer | Mark S. Verratti Chief Commercial Officer |
Business Overview |
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company's testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight. |
Financial Overview |
For the fiscal year ended 31 December 2023, Myriad Genetics, Inc. revenues increased 11% to $753.2M. Net loss increased from $112M to $263.3M. Revenues reflect United States segment increase of 14% to $671.7M. Higher net loss reflects Legal settlements increase from $0K to $112.8M (expense), SBC in Gen and Admin increase of 10% to $529.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.39 to -$3.18. |
Employees: | 2,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,583M as of Dec 31, 2023 |
Annual revenue (TTM): | $753.20M as of Dec 31, 2023 |
EBITDA (TTM): | -$75.00M as of Dec 31, 2023 |
Net annual income (TTM): | -$263.30M as of Dec 31, 2023 |
Free cash flow (TTM): | -$184.20M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 90,478,255 as of Apr 11, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |